Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [T cell]

ABSTRACT: To investigate how DC cells treated with SPI1 inhibitor (DB2313) affected the function of primary T cells. We then performed gene expression profiling analysis using data obtained from RNA-seq of primary T cells incubated with DC cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE245666 | GEO | 2024/05/29

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [DC]

Project description:To investigated how SPI1 inhibitor (DB2313) affected the function of DCs , we treated BMDM derived DCs,with DB2313. We then performed gene expression profiling analysis using data obtained from RNA-seq of peritoneal DCs with DB2313

2024-05-29 | GSE245183 | GEO

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-05-29 | GSE245667 | GEO

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [DC]

Project description:C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [DC]

| PRJNA1027330 | ENA

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development

Project description:C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development

| PRJNA1029542 | ENA

C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [T cell]

Project description:C1Q+macrophage interacts with activated CD8+ promoting atherosclerosis development [T cell]

| PRJNA1029556 | ENA

Reprogram glioblastoma (GBM) human cell line into DC

Project description:3 human GBM cell lines were reprogrammed into DC by lentiviral vectors containing SPI1, IKZF1

2024-10-23 | GSE270857 | GEO

Transgenic NUP98-HOXA9 Zebrafish Embryos: Unactivated ('lGl') vs. Cre-activated ('NHA9')

Project description:Transcriptional profiling of zebrafish embryos at 28 hours post fertilization, comparing control 'unactivated' Tg(spi1::lox-eGFP-lox::NHA9) embryos with experimental 'Cre-activated' Tg(spi1::NHA9) embryos. Goal was to determine the effects of expressing NUP98-HOXA9 oncogene on global and blood cell-specific gene expression in early zebrafish development. Two-condition experiment, unactivated 'lGl' embryos vs. Cre-activated 'NHA9' embryos. Biological replicates: 2 control replicates, 2 experimental replicates.

2014-10-30 | E-GEOD-62793 | biostudies-arrayexpress

Heme interacts with c1q and inhibits the classical complement pathway.

Project description:C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme significantly reduced the activation of the classical complement pathway, mediated by C-reactive protein (CRP) and IgG. Interaction analyses revealed that heme reduces the binding of C1q to CRP and IgG. Furthermore, we demonstrated that the inhibition of C1q interactions results from a direct binding of heme to C1q. Formation of complex of heme with C1q caused changes in the mechanism of recognition of IgG and CRP. Taken together, our data suggest that heme is a natural negative regulator of the classical complement pathway at the level of C1q. Heme may play a role at sites of excessive tissue damage and hemolysis where large amounts of free heme are released.

| S-EPMC3091251 | biostudies-literature

Transgenic NUP98-HOXA9 Zebrafish Embryos: Unactivated ('lGl') vs. Cre-activated ('NHA9')

2014-10-30 | GSE62793 | GEO

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2.

Project description:Monogenic forms of vasculitis are rare but increasingly recognized. Furthermore, genetic immunodeficiency is increasingly associated with inflammatory immune dysregulatory features, including vasculitis. This case report describes a child of non-consanguineous parents who presented with chronic digital vasculitis early in life, is of short stature, has facial dysmorphia, immunodeficiency (low serum IgA, high serum IgM), recurrent bacterial infections, lymphoproliferation, absence of detectable serum C1q, and low classical complement pathway activity. We identified a previously reported de novo heterozygous pathogenic splice mutation in PIK3R1 (c.1425 + 1G > A), resulting in the skipping of exon 11 of the p85α subunit of phosphatidylinositol 3-kinase and causing activated PI3Kδ syndrome type II (APDS2). This explained the phenotype, with the exception of digital vasculitis and C1q deficiency, which have never been described in association with APDS2. No mutations were identified in C1QA, B, or C, their promoter regions, or in any other complement component. Functional studies indicated normal monocytic C1q production and release, suggesting that the observed C1q deficiency was caused by peripheral consumption of C1q. Since C1q deficiency has never been associated with APDS2, we assessed C1q levels in two unrelated patients with genetically confirmed APDS2 and confirmed C1q deficiency in those two cases as well. This observation suggests C1q deficiency to be an inherent but previously unrecognized feature of APDS2. We speculate that the consumption of C1q is driven by increased apoptotic bodies derived from immune cellular senescence, combined with elevated IgM production (both inherent features of APDS2). Secondary C1q deficiency in APDS2 may further contribute to immunodeficiency and could also be associated with inflammatory immune dysregulatory phenotypes, such as the digital vasculitis observed in our case.

| S-EPMC6859795 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data